MIAMI, Florida – After 60 years of marriage, Frank and Juanita Buggs have made many memories together.
"We have two children and four grandchildren and two great grandchildren," said Frank.
But ten years ago, Frank noticed changes in his wife's memory.
She was diagnosed with Alzheimer's disease.
Dr. Marc Agronin says the disease can start with short-term memory deficits, but then progresses. And because Alzheimer's causes inflammation in the brain it can also lead to behavioral changes.
"We see changes in mood, people get very reactive to situations, stressful situations, they get very anxious or sometimes depressed," explained Dr. Agroni, Senior Vice President for Behavioral Health at Miami Jewish Health.
At night, Juanita gets aggravated when Frank is trying to give her her medication. He turned to Miami Jewish Health which is studying a drug to help Alzheimer's patients with agitation.
"She participated in the double blind, placebo-controlled portion of the study," said Dr. Ricardo Castaneda, director of Clinical Research and Business Development at Miami Jewish Health.
Now Juanita gets the experimental drug by Avanir Pharmaceuticals as part of the open label extension.
NEW TREATMENT: The Miami Jewish Health Center is testing a drug, Eli Lilly (TrailBlazer-ALZ) 15T-MC-AACG, that could also stabilize the mood swings of Alzheimer's patients over six months. Dr. Agronim says researchers are trying trials like this to improve cognition and provide wellness. Another possible treatment being tested is immunotherapy, which would get the immune system to attack the disease itself.
"It's going to help somebody," said Frank.
Frank knows this medication may not mean big changes for Juanita, but he has his eye on the future.
"We just need to find a cure soon."
If this story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Jim Mertens at firstname.lastname@example.org or Marjorie Bekaert Thomas at email@example.com.